Arq. Bras. Oftalmol. 2022; 85 (4): 10.5935/0004-2749.20220039
Total: 2825
Carlos Rocha-de-Lossada1Δ; Carmen Alba Linero1Δ; Álvaro Santos Ortega1; Marina Rodríguez Calvo-de-Mora1; Rahul Rachwani1; Davide Borroni2,3; Emilio Alba4; Manuel Benavides Orgaz4; Vito Romano2
DOI: 10.5935/0004-2749.20220039
1. Ophthalmology Department, Hospital Regional Universitario de Málaga, Málaga, Spain
2. Royal Liverpool University Hospital, Liverpool, United Kingdom
3. Department of Doctoral Studies, Riga Stradins University, Latvia
4. Unidad de gestión clínica, Oncología Médica Hospital Regional y Universitario de Málaga. Instituto de Investigación de Biotecnología de Málaga, Málaga, Spain
Carmen Alba-Linero
E-mail: [email protected]
Funding: This study received no specific financial support
Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose
Informed consent was obtained from all patients included in this study
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
